Effects of HLA-G on accumulation of myeloid-derived suppressor cells (MDSC) and successful pregnancy
Effects of HLA-G on accumulation of myeloid-derived suppressor cells (MDSC) and successful pregnancy
批准号:
357709457
负责人:
Dr. Natascha Köstlin-Gille
金额:
$0.0万
依托单位国家:
德国
项目类别:
Research Grants
财政年份:
2017
资助国家:
德国
项目状态:
已结题
起止时间:
2016-12-31 至 2019-12-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Miscarriage is the most important pregnancy complication, affecting up to 50% of women. Maternal immune system plays an important role in pathogenesis of miscarriage. Myeloid-derived suppressor cells (MDSC) are myeloid cells with suppressive activity on other immune cells and are known to accumulate during pregnancy. It was hypothesized that MDSC are important for maintenance of maternal-fetal tolerance and successful pregnancy. Until now, only little is known about factors regulating MDSC accumulation and function during pregnancy. Human leucocyte antigen (HLA) G is expressed during pregnancy by cells of the fetal placenta. It regulates various immune functions in order to avoid rejection of the fetus by maternal immune cells. In this project, we aim to prove the hypothesis that HLA-G induces MDSC during pregnancy thereby preventing miscarriage. In a clinical study we aim to analyze correlation between levels of soluble HLA-G (sHLA-G) and MDSC numbers. In in vitro experiments with murine cells the effect of sHLA-G on MDSC-function will be investigated. Last, it will be examined how lack of HLA-G, respectively its murine correlate Qa2, affects murine pregnancy and if application of HLA-G can reduce incidence of abortions in two in vivo mouse models. The results of the study can help to a better understanding of immunological processes leading to pregnancy failure and to develop therapeutic strategies for prevention of miscarriage.
期刊论文(5)
专著(0)
科研奖励(0)
会议论文
DOI:
10.3389/fimmu.2019.00161
发表时间:
2019-02-05
期刊:
FRONTIERS IN IMMUNOLOGY
影响因子:
7.3
作者:
[Koestlin-Gille, Natascha, Dietz, Stefanie, Gille, Christian]
通讯作者:
Gille, Christian
DOI:
10.1038/s41390-019-0504-7
发表时间:
2019-11-01
期刊:
PEDIATRIC RESEARCH
影响因子:
3.6
作者:
[Dietz, Stefanie, Schwarz, Julian, Koestlin-Gille, Natascha]
通讯作者:
Koestlin-Gille, Natascha
The role of myeloid derived suppressor cells (MDSC) from breast milk for immune development of the neonate
-
批准号:431535861
-
项目类别:Research Grants
-
资助金额:$0.0万
-
财政年份:2019
-
负责人:Dr. Natascha Köstlin-Gille
-
依托单位:
国内基金
海外基金
登录
查看更多内容
LILRB2/HLA-G免疫抑制轴在胶质瘤干细胞免疫逃逸中的作用及其与STAT3信号通路的交互调控机制研究
-
批准号:2026JJ80459
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:王彪
-
依托单位:
HLA-DR+中性粒细胞调控儿童噬血细胞综合征细胞因子风暴的机制及临床价值研究
-
批准号:2026JJ81611
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:刘灿
-
依托单位:
HLA-B*13:01介导阿苯达唑肝损伤的毒理机制及构效关系研究
-
批准号:2026JJ50638
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:饶泰
-
依托单位:
肝内胆管细胞癌中TREM2+巨噬细胞通过增强HLA-C/FAM3C信号通路依赖性淋巴管生成促进肿瘤转移的机制研究
-
批准号:QN25H160111
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:万喆
-
依托单位:
HLA-B27通过肠道菌群失衡致炎促AS发展的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:郑海雅
-
依托单位:
三阴性乳腺癌HLA-I和HLA-II限制性T细胞表位鉴定与免疫治疗
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:邵营宽
-
依托单位:
EBV高危亚型编码的BALF2-HR蛋白上调HLA-II类分子促进鼻咽癌免疫逃逸的机制研究
-
批准号:2025JJ60152
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:葛军尚
-
依托单位:
HLA-C 提高CAR-T 细胞治疗急性淋巴细胞白血病效能及机制的探讨
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:张诚
-
依托单位:
HLA-G在胃癌发生发展中的作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:章霞
-
依托单位:
KIR-HLA受配体相合度对免疫性血小板输注无效的影响及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:
-
依托单位: